Abinet Abebe

Mr. Abinet Abebe

Mizan Tepi University, Mīzan Teferī, Ethiopia
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AAAbinet Abebe
Abinet Abebe
KKKabaye Kumela
Kabaye Kumela
MBMaekel Belay
Maekel Belay
BKBezie Kebede
Bezie Kebede
YWYohannes Wobie
Yohannes Wobie
Acute kidney injury (AKI) is a major global public health problem. It is expensive to manage and associated with a high rate of prolonged hospitalization and in-hospital mortality. Little is known about the burden of acute kidney injury in moderate to low-income countries. We aim to assess predictors of in-hospital mortality among AKI patients admitted to the medical ward. We prospectively identified patients meeting kidney disease improving global outcomes (KIDGO) AKI definitions from April to August 2019. Patients with underlying CKD and patients hospitalized for less than 48 h were excluded. The Cox regression model was fitted to identify predictors of mortality and statistical significance was considered at the p-value of less than 0.05. A total of 203 patients were enrolled over 5 months. Out of this, 121(59.6%) were males, 58(28.6%) were aged greater than 60 years, and 141(69.5%) had community-acquired acute kidney injury. The most common causes of AKI were Hypovolemia 99(48.77%), Glomerulonephritis 51(25.11%), and sepsis 32(15.79%). The overall in-hospital mortality rate was 12.8%. Stage 3 AKI (AHR = 9.61, 95% CI 1.17–28.52, p = 0.035), duration of AKI (AHR = 7.04, 95% CI 1.37–36.08, p = 0.019), length of hospital stay (AHR = 0.19, 95% CI 0.05–0.73, p = 0.012), and hyperkalemia (AHR = 3.61, 95% CI 1.12–11.71, p = 0.032) were significantly associated with in-hospital mortality. There is a high rate of acute kidney injury-related in-hospital mortality in adult patients admitted to the medical ward. The severity of AKI, hyperkalemia duration of AKI, and a short length of hospital stay were predictors of 30-days in-hospital mortality. Most of the causes of AKI are preventable and patients may benefit from early identification and treatment of these reversible causes.

10 February 2023 in Medicine
Verified
Journal Article
Open access
FBFilagot Md Bishaw
Filagot Md Bishaw
MWMaekel Md Belay Woldemariam
Maekel Md Belay Woldemariam
GMGashahun Md Mekonen
Gashahun Md Mekonen
BBBezawit Birhanu
Bezawit Birhanu
AAAbinet Abebe
Abinet Abebe
Anemia is a common complication of chronic kidney disease (CKD) and is associated with adverse patient outcomes. However, data on the prevalence of anemia in CKD patients is sparse, particularly in resource-limited settings. Therefore, this study aimed to assess the prevalence of anemia and its predictors among patients with CKD admitted to the Jimma medical center, southwest Ethiopia. A hospital-based prospective cross-sectional study was conducted from September 1 to November 30, 2020. All adult patients with CKD aged ≥18 years who fulfilled the inclusion criteria were consecutively recruited into the study. Data were entered into the Epi data manager version 4.4.1 and then exported to SPSS version 22 (IBM Corp., Armonk, NY) for analysis. The predictors of anemia were determined using multivariable logistic regression analysis. Statistical significance was set at P < .05. A total of 150 patients were included in this study. Of these, 64.67% were male, 56.67% had stage 5 CKD, 78% had a CKD duration of less than 1 year, and 74% had proteinuria. Hypertension (40.7%) and diabetes (14.7%) were the common causes of CKD. The prevalence of anemia was 85.33%. Of the patients, 28.67%, 40.67%, and 16% had mild, moderate, and severe anemia, respectively. On multivariate logistic regression, stage 4 CKD (adjusted odds ratio [AOR] 3.2, confidence interval [CI]: 1.78–12.91, P = .025), stage 5 CKD (AOR 4.03, CI: 1.17–13.73, P = .016), and CKD duration of less than 1 year (AOR 3, CI: 1.19–9.11, P = .007) were significantly associated with anemia. The prevalence of anemia among stage 3 to 5 CKD patients was very high. Anemia was significantly associated with the severity and duration of CKD. Therefore, serial follow-up of patients with a long duration and advanced stages of CKD may help prevent anemia and its adverse consequences.

4 April 2022 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
AAAbinet Abebe
Abinet Abebe
YWYohannes Wobie
Yohannes Wobie
BZbezie zelalem
bezie zelalem
AWAlemnew Wale
Alemnew Wale
ADAlemnew Destaw
Alemnew Destaw
AAAbyou Seyfu Ambaye
Abyou Seyfu Ambaye

1 September 2021 in Pediatric Health, Medicine and Therapeutics
Verified
Journal Article
Open access
PDF file
AWAlemnew Wale
Alemnew Wale
LCLegese Chelkeba
Legese Chelkeba
YWYohannes Wobie
Yohannes Wobie
AAAbinet Abebe
Abinet Abebe
Introduction: Neonatal sepsis is the gravest problem in neonates, ending in significant morbidity and mortality. World wide 6.9 million neonates were spotted with potentially severe bacterial infections needing treatment and 2.6 million of them occurred in sub-Saharan Africa (SSA). Sepsis is the leading cause of neonatal mortality and is perhaps answerable for about 30– 50% of the total neonatal deaths per year in emerging countries. Objective: This study aims to assess the treatment outcome and associated factors of neonatal sepsis at Mizan Tepi University Teaching Hospital, South West Ethiopia. Methods: A hospital-based prospective observational study was done at Mizan Tepi University Teaching Hospital (MTUTH) from May to November 2019 among neonates admitted with sepsis. Data were entered to Epi-data 4.2 and analyzed by SPSS version 21. Bivariate and multivariate Cox regression was used to identify the relationship between dependent and independent variables. All neonates ≤ 28 days who were admitted to MTUTH at the neonatal intensive care unit (NICU) and neonates diagnosed with sepsis by the attending physician either clinically or laboratory-confirmed included in the study. Results: Of the 211 neonatal sepsis patients, 110 (52.1%) were females, 161 (76.3%) were admitted with late-onset sepsis, 16 (7.6%) were very low birth weight, and 156 (73.9%) were term. About 143 (67.8%) had a good outcome and 68 (32.2%) had a poor outcome. Very low birth weight [P = 0.006, AHR = 1.692, 95% CI: (1.245, 4.36)], age of neonate being less than 4 days at admission [P = 0.001, AHR = 9.67, 95% CI: (2.24, 41.70)], maternal infection [P = 0.032, AHR = 3.186, 95% CI: (1.32, 30.68)], and prolonged length of hospital stay [(P = 0.017, AHR = 12.29, 95% CI: (1.55, 96.31), were significantly associated to mortality. Conclusion: The mortality rate of neonatal sepsis was found to be high. Age of neonate < 4 days, birth weight of the neonate < 1500 gm, and prolonged length of hospital stay were identified as independently associated factors of increased risk of mortality.

1 July 2021 in International Journal of Nephrology and Renovascular Disease
Verified
Journal Article
Open access
PDF file
AAAbinet Abebe
Abinet Abebe
BZbezie zelalem
bezie zelalem
YWYohannes Wobie
Yohannes Wobie
Background: Acute kidney injury (AKI) is a common complication in hospitalized patients and a marker for poor patient outcomes. It is associated with a high risk of mortality and other short- and long-term adverse outcomes. We aim to assess the clinical profile and short-term outcomes of acute kidney injury in adult patients admitted to the medical ward. Methods: A hospital-based prospective observational study was conducted from October 2019 to January 2020. All adult patients diagnosed as AKI using kidney disease improving global outcomes (KIDGO) criteria were included in the study and prospectively followed to document the short-term outcomes. Outcomes and their predictors were determined using multivariate logistic regression. P-value less than 0.05 was taken as statistically significant. Results: A total of 160 patients were included in the study. Out of this, 96 (60%) were males, 118 (74%) had community-acquired AKI, and 51 (32%) had stage 3 AKI. Common causes of AKI were hypovolemia 62 (39%) and sepsis 35 (22%). Hypertension 69 (43%) and heart failure 50 (31%) were common underlying comorbidities. Fifty-six (35%) patients developed systemic complications, 98 (61.2%) had persistent AKI, 136 (85%) had prolonged length of hospital stay, and 18 (11%) were readmitted to the hospital. The presence of AKI-related complication (AOR=2.7, 95% CI: 1.14– 6.58, p=0.024), and duration of AKI (AOR=9.7, 95% CI: 2.56– 36.98, p=0.001) were factors associated with prolonged length of hospital stay. Preexisting CKD (AOR=3.6, 95% CI: 1.02– 13.14, p=0.035) and stage 3 AKI (AOR=2.1, 95% CI: 1.6– 3.57, p=0.04) were factors associated with 30-day hospital readmission. Conclusion: Hypovolemia and infections were the primary causes of AKI. Complications, prolonged length of hospital stay, persistent AKI, and rehospitalization were poor short-term outcomes of AKI. Early diagnosis and timely management of AKI particularly in high-risk hospitalized patients, and post-AKI care including management of comorbidities for AKI survivors should improve these poor short-term outcomes.

14 November 2025 in Medicine
Verified
Journal Article
Open access
AAAbinet Abebe
Abinet Abebe
MBMaekel Belay
Maekel Belay
EAErkihun Assefa
Erkihun Assefa
Little is known about renal recovery after acute kidney injury (AKI), particularly in countries with limited resources. This study aimed to explore the patterns of renal recovery and predictors of renal non-recovery among hospitalized patients with AKI in Ethiopia. A prospective observational study was conducted involving all adult patients aged ≥18 years, who met the kidney disease: improving global outcomes criteria for AKI from April to July 2019. The main outcome variable was renal recovery, defined as reversal at discharge or return to baseline kidney function. Reversal from an AKI episode was defined as no longer meeting AKI criteria. Non-recovery was defined as AKI that did not return to baseline kidney function at hospital discharge. A logistic regression model was used to determine the predictors of non-recovery AKI. Statistical significance was considered at a P -value of <.05 on multivariate analysis. Of the 169 patients included in the study over 4 months, one-third (33.1%) had stage 3 AKI, nearly half (50.29%) had pre AKI, and 32 (19%) had exposure to nephrotoxic drugs. Of these, 115 (68%) had complete renal recovery, and 54 (32%) had non-recovery AKI. In patients with complete recovery, 17 (10%) had early sustained reversal, 78 (46%) had late sustained reversal, and the remaining 20 (12%) had relapsing AKI with complete recovery. Among patients with non-recovery AKI, 23 (13.6%) had relapsing AKI without recovery, and 31 (18.4%) did not recover during their hospital stay. A higher rate of non-recovery was observed in patients with severe AKI. Stage III AKI (adjusted odds ratio: 4.7, confidence interval: 1.37–28.6, P = .019) and nephrotoxic drug use (adjusted odds ratio: 5.2, confidence interval: 2.1–14.89, P = .007) were significantly associated with renal non-recovery. The study found that around two-thirds of the patients had complete renal recovery and nearly one-third had non-recovery AKI at hospital discharge. Renal non-recovery was significantly associated with the severity of AKI and the use of nephrotoxic drugs. Close monitoring of serum creatinine levels and careful drug use monitoring may help identify patients with poor prognosis, initiate specific interventions, and improve renal recovery.